Dumoulin, M. In Protein Misfolding Diseases: Basis of Protein Misfolding, Pathophysiology, Current, and Emerging Therapies; Ramirez-Alvarado, M., Kelley, J. W., Dobson, C. M., Eds.; John Wileys and Sons, Inc.: Hoboken, NJ, 2012; pp 867-884.
Dumoulin, M.; Kumita, J. R.; Dobson, C. M. Normal and Aberrant Biological Self-Assembly: Insights from Studies of Human Lysozyme and Its Amyloidogenic Variants Acc. Chem. Res. 2006, 39, 603-610
Radford, S. E. Protein Folding: Progress Made and Promises Ahead Trends Biochem. Sci. 2000, 25, 611-618
Pepys, M. B.; Hawkins, P. N.; Booth, D. R.; Vigushin, D. M.; Tennent, G. A.; Soutar, A. K.; Totty, N.; Nguyen, O.; Blake, C. C.; Terry, C. J. Human Lysozyme Gene Mutations Cause Hereditary Systemic Amyloidosis Nature 1993, 362, 553-557
Booth, D. R.; Pepys, M. B.; Hawkins, P. N. A Novel Variant of Human Lysozyme (T70N) Is Common in the Normal Population Hum. Mutat. 2000, 16, 180
Röcken, C.; Becker, K.; Fändrich, M.; Schroeckh, V.; Stix, B.; Rath, T.; Kähne, T.; Dierkes, J.; Roessner, A.; Albert, F. W. ALys Amyloidosis Caused by Compound Heterozygosity in Exon 2 (Thr70Asn) and Exon 4 (Trp112Arg) of the Lysozyme Gene Hum. Mutat. 2006, 27, 119-120
Valleix, S.; Drunat, S.; Philit, J. B.; Adoue, D.; Piette, J. C.; Droz, D.; MacGregor, B.; Canet, D.; Delpech, M.; Grateau, G. Hereditary Renal Amyloidosis Caused by a New Variant Lysozyme W64R in a French Family Kidney Int. 2002, 61, 907-912
Yazaki, M.; Farrell, S. A.; Benson, M. D. A Novel Lysozyme Mutation Phe57Ile Associated with Hereditary Renal Amyloidosis Kidney Int. 2003, 63, 1652-1657
Girnius, S.; Skinner, M.; Spencer, B.; Prokaeva, T.; Bartholomew, C.; O'Hara, C.; Seldin, D. C.; Connors, L. H. A New Lysozyme Tyr54Asn Mutation Causing Amyloidosis in a Family of Swedish Ancestry with Gastrointestinal Symptoms Amyloid 2012, 19, 182-185
Dumoulin, M.; Johnson, J. R.; Bellotti, V.; Dobson, C. M. In Protein Misfolding, Aggregation, and Conformational Diseases; Uversky, V. N.; Fink, A., Eds.; Springer: New York, 2007; Vol. 6, pp 285-308.
Booth, D. R.; Sunde, M.; Bellotti, V.; Robinson, C. V.; Hutchinson, W. L.; Fraser, P. E.; Hawkins, P. N.; Dobson, C. M.; Radford, S. E.; Blake, C. C. Instability, Unfolding and Aggregation of Human Lysozyme Variants Underlying Amyloid Fibrillogenesis Nature 1997, 385, 787-793
Canet, D.; Last, A. M.; Tito, P.; Sunde, M.; Spencer, A.; Archer, D. B.; Redfield, C.; Robinson, C. V.; Dobson, C. M. Local Cooperativity in the Unfolding of an Amyloidogenic Variant of Human Lysozyme Nat. Struct. Mol. Biol. 2002, 9, 308-315
Canet, D.; Sunde, M.; Last, A. M.; Miranker, A.; Spencer, A.; Robinson, C. V.; Dobson, C. M. Mechanistic Studies of the Folding of Human Lysozyme and the Origin of Amyloidogenic Behavior in Its Disease-Related Variants Biochemistry 1999, 38, 6419-6427
Chamberlain, A. K.; Receveur, V.; Spencer, A.; Redfield, C.; Dobson, C. M. Characterization of the Structure and Dynamics of Amyloidogenic Variants of Human Lysozyme by Nmr Spectroscopy Protein Sci. 2001, 10, 2525-2530
Dhulesia, A.; Cremades, N.; Kumita, J. R.; Hsu, S. T.; Mossuto, M. F.; Dumoulin, M.; Nietlispach, D.; Akke, M.; Salvatella, X.; Dobson, C. M. Local Cooperativity in an Amyloidogenic State of Human Lysozyme Observed at Atomic Resolution J. Am. Chem. Soc. 2010, 132, 15580-15588
Funahashi, J.; Takano, K.; Ogasahara, K.; Yamagata, Y.; Yutani, K. The Structure, Stability, and Folding Process of Amyloidogenic Mutant Human Lysozyme J. Biochem. 1996, 120, 1216-1223
Morozova-Roche, L. A.; Zurdo, J.; Spencer, A.; Noppe, W.; Receveur, V.; Archer, D. B.; Joniau, M.; Dobson, C. M. Amyloid Fibril Formation and Seeding by Wild-Type Human Lysozyme and Its Disease-Related Mutational Variants J. Struct. Biol. 2000, 130, 339-351
Takano, K.; Funahashi, J.; Yutani, K. The Stability and Folding Process of Amyloidogenic Mutant Human Lysozymes Eur. J. Biochem. 2001, 268, 155-159
Wain, R.; Smith, L. J.; Dobson, C. M. Oxidative Refolding of Amyloidogenic Variants of Human Lysozyme J. Mol. Biol. 2005, 351, 662-671
Buell, A. K.; Dhulesia, A.; Mossuto, M. F.; Cremades, N.; Kumita, J. R.; Dumoulin, M.; Welland, M. E.; Knowles, T. P.; Salvatella, X.; Dobson, C. M. Population of Nonnative States of Lysozyme Variants Drives Amyloid Fibril Formation J. Am. Chem. Soc. 2011, 133, 7737-7743
Esposito, G.; Garcia, J.; Mangione, P.; Giorgetti, S.; Corazza, A.; Viglino, P.; Chiti, F.; Andreola, A.; Dumy, P.; Booth, D. Structural and Folding Dynamics Properties of T70N Variant of Human Lysozyme J. Biol. Chem. 2003, 278, 25910-25918
Johnson, R. J.; Christodoulou, J.; Dumoulin, M.; Caddy, G. L.; Alcocer, M. J.; Murtagh, G. J.; Kumita, J. R.; Larsson, G.; Robinson, C. V.; Archer, D. B. Rationalising Lysozyme Amyloidosis: Insights from the Structure and Solution Dynamics of T70N Lysozyme J. Mol. Biol. 2005, 352, 823-836
Hagan, C. L.; Johnson, R. J.; Dhulesia, A.; Dumoulin, M.; Dumont, J.; De Genst, E.; Christodoulou, J.; Robinson, C. V.; Dobson, C. M.; Kumita, J. R. A Non-Natural Variant of Human Lysozyme (I59T) Mimics the in Vitro Behaviour of the I56T Variant That Is Responsible for a Form of Familial Amyloidosis Protein Eng., Des. Sel. 2010, 23, 499-506
Dobson, C. M. Protein Folding and Misfolding Nature 2003, 426, 884-890
Chiti, F.; Dobson, C. M. Amyloid Formation by Globular Proteins under Native Conditions Nat. Chem. Biol. 2009, 5, 15-22
Dobson, C. M. Principles of Protein Folding, Misfolding and Aggregation Semin. Cell Dev. Biol. 2004, 15, 3-16
Dumoulin, M.; Canet, D.; Last, A. M.; Pardon, E.; Archer, D. B.; Muyldermans, S.; Wyns, L.; Matagne, A.; Robinson, C. V.; Redfield, C. Reduced Global Cooperativity Is a Common Feature Underlying the Amyloidogenicity of Pathogenic Lysozyme Mutations J. Mol. Biol. 2005, 346, 773-788
Dumoulin, M.; Last, A. M.; Desmyter, A.; Decanniere, K.; Canet, D.; Larsson, G.; Spencer, A.; Archer, D. B.; Sasse, J.; Muyldermans, S. A Camelid Antibody Fragment Inhibits the Formation of Amyloid Fibrils by Human Lysozyme Nature 2003, 424, 783-788
Frare, E.; Mossuto, M. F.; Polverino de Laureto, P.; Dumoulin, M.; Dobson, C. M.; Fontana, A. Identification of the Core Structure of Lysozyme Amyloid Fibrils by Proteolysis J. Mol. Biol. 2006, 361, 551-561
Muyldermans, S. Single Domain Camel Antibodies: Current Status J. Biotechnol. 2001, 74, 277-302
Chan, P.-H.; Pardon, E.; Menzer, L.; De Genst, E.; Kumita, J. R.; Christodoulou, J.; Saerens, D.; Brans, A.; Bouillenne, F.; Archer, D. A. Engineering a Camelid Antibody Fragment That Binds to the Active Site of Human Lysozyme and Inhibits Its Conversion into Amyloid Fibrils Biochemistry 2008, 47, 11041-11054
De Genst, E.; Dobson, C. M. Nanobodies as Structural Probes of Protein Misfolding and Fibril Formation Methods Mol. Biol. 2012, 911, 533-558
Conrath, K. E.; Lauwereys, M.; Galleni, M.; Matagne, A.; Frere, J. M.; Kinne, J.; Wyns, L.; Muyldermans, S. Beta-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae Antimicrob. Agents Chemother. 2001, 45, 2807-2812
Arbabi Ghahroudi, M.; Desmyter, A.; Wyns, L.; Hamers, R.; Muyldermans, S. Selection and Identification of Single Domain Antibody Fragments from Camel Heavy-Chain Antibodies FEBS Lett. 1997, 414, 521-526
Dumoulin, M.; Conrath, K.; Van Meirhaeghe, A.; Meersman, F.; Heremans, K.; Frenken, L. G.; Muyldermans, S.; Wyns, L.; Matagne, A. Single-Domain Antibody Fragments with High Conformational Stability Protein Sci. 2002, 11, 500-515
Chen, Z.; Ruffner, D. E. Amplification of Closed Circular DNA in Vitro Nucleic Acids Res. 1998, 26, 1126-1127
Spencer, A.; Morozova-Roche, L. A.; Noppe, W.; MacKenzie, D. A.; Jeenes, D. J.; Joniau, M.; Dobson, C. M.; Archer, D. B. Expression, Purification, and Characterization of the Recombinant Calcium-Binding Equine Lysozyme Secreted by the Filamentous Fungus Aspergillus Niger: Comparisons with the Production of Hen and Human Lysozymes Protein Expression Purif. 1999, 16, 171-180
Pace, C. N.; Vajdos, F.; Fee, L.; Grimsley, G.; Gray, T. How to Measure and Predict the Molar Absorption Coefficient of a Protein Protein Sci. 1995, 4, 2411-2423
Delaglio, F.; Grzesiek, S.; Vuister, G. W.; Zhu, G.; Pfeifer, J.; Bax, A. Nmrpipe: A Multidimensional Spectral Processing System Based on Unix Pipes J. Biomol. NMR 1995, 6, 277-293
Borek, D.; Minor, W.; Otwinowski, Z. Measurement Errors and Their Consequences in Protein Crystallography Acta Crystallogr., Sect. D: Biol. Crystallogr. 2003, 59, 2031-2038
McCoy, A. J.; Grosse-Kunstleve, R. W.; Adams, P. D.; Winn, M. D.; Storoni, L. C.; Read, R. J. Phaser Crystallographic Software J. Appl. Crystallogr. 2007, 40, 658-674
Adams, P. D.; Afonine, P. V.; Bunkóczi, G.; Chen, V. B.; Davis, I. W.; Echols, N.; Headd, J. J.; Hung, L. W.; Kapral, G. J.; Grosse-Kunstleve, R. W. Phenix: A Comprehensive Python-Based System for Macromolecular Structure Solution Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 213-221
Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Refinement of Macromolecular Structures by the Maximum-Likelihood Method Acta Crystallogr., Sect. D: Biol. Crystallogr. 1997, 53, 240-255
Emsley, P.; Cowtan, K. Coot: Model-Building Tools for Molecular Graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 2126-2132
Jones, S.; Thornton, J. M. Principles of Protein-Protein Interactions Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 13-20
Lee, B.; Richards, F. M. The Interpretation of Protein Structures: Estimation of Static Accessibility J. Mol. Biol. 1971, 55, 379-400
Winn, M. D.; Ballard, C. C.; Cowtan, K. D.; Dodson, E. J.; Emsley, P.; Evans, P. R.; Keegan, R. M.; Krissinel, E. B.; Leslie, A. G.; McCoy, A. Overview of the Ccp4 Suite and Current Developments Acta Crystallogr., Sect. D: Biol. Crystallogr. 2011, 67, 235-242
McDonald, I. K.; Thornton, J. M. Satisfying Hydrogen Bonding Potential in Proteins J. Mol. Biol. 1994, 238, 777-793
Transue, T. R.; De Genst, E.; Ghahroudi, M. A.; Wyns, L.; Muyldermans, S. Camel Single-Domain Antibody Inhibits Enzyme by Mimicking Carbohydrate Substrate Proteins 1998, 32, 515-522
Davies, J.; Riechmann, L. Single Antibody Domains as Small Recognition Units: Design and in Vitro Antigen Selection of Camelized, Human VH Domains with Improved Protein Stability Protein Eng., Sel. Des. 1996, 9, 531-537
De Genst, E.; Saerens, D.; Muyldermans, S.; Conrath, K. Antibody Repertoire Development in Camelids Dev. Comp. Immunol. 2006, 30, 187-198
Muyldermans, S.; Cambillau, C.; Wyns, L. Recognition of Antigens by Single-Domain Antibody Fragments: The Superfluous Luxury of Paired Domains Trends Biochem. Sci. 2001, 26, 230-235
Ermolenko, D. N.; Zherdev, A. V.; Dzantiev, B. B. Antibodies as Specific Chaperones Biochemistry 2004, 69, 1233-1238
Saerens, D.; Pellis, M.; Loris, R.; Pardon, E.; Dumoulin, M.; Matagne, A.; Wyns, L.; Muyldermans, S.; Conrath, K. Identification of a Universal Vhh Framework to Graft Non-Canonical Antigen-Binding Loops of Camel Single-Domain Antibodies J. Mol. Biol. 2005, 352, 597-607
Cremades, N.; Cohen, S. I.; Deas, E.; Abramov, A. Y.; Chen, A. Y.; Orte, A.; Sandal, M.; Clarke, R. W.; Dunne, P.; Aprile, F. A. Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein Cell 2012, 149, 1048-1059
Breydo, L.; Wu, J. W.; Uversky, V. N. α-Synuclein Misfolding and Parkinson's Disease Biochim. Biophys. Acta 2012, 1822, 261-285
Narayan, P.; Orte, A.; Clarke, R. W.; Bolognesi, B.; Hook, S.; Ganzinger, K. A.; Meehan, S.; Wilson, M. R.; Dobson, C. M.; Klenerman, D. The Extracellular Chaperone Clusterin Sequesters Oligomeric Forms of the Amyloid-Beta(1-40) Peptide Nat. Struct. Mol. Biol. 2012, 19, 79-83
Rochet, J. C.; Lansbury, P. T., Jr. Amyloid Fibrillogenesis: Themes and Variations Curr. Opin. Struct. Biol. 2000, 10, 60-68
Lee, J.; Culyba, E. K.; Powers, E. T.; Kelly, J. W. Amyloid-Beta Forms Fibrils by Nucleated Conformational Conversion of Oligomers Nat. Chem. Biol. 2011, 7, 602-609
Giehm, L.; Svergun, D. I.; Otzen, D. E.; Vestergaard, B. Low-Resolution Structure of a Vesicle Disrupting α-Synuclein Oligomer That Accumulates during Fibrillation Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 3246-3251
Grimster, N. P.; Connelly, S.; Baranczak, A.; Dong, J.; Krasnova, L. B.; Sharpless, K. B.; Powers, E. T.; Wilson, I. A.; Kelly, J. W. Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate J. Am. Chem. Soc. 2013, 135, 5656-5668
Bulawa, C. E.; Connelly, S.; Devit, M.; Wang, L.; Weigel, C.; Fleming, J. A.; Packman, J.; Powers, E. T.; Wiseman, R. L.; Foss, T. R. Tafamidis, a Potent and Selective Transthyretin Kinetic Stabilizer That Inhibits the Amyloid Cascade Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 9629-9634
Alhamadsheh, M. M.; Connelly, S.; Cho, A.; Reixach, N.; Powers, E. T.; Pan, D. W.; Wilson, I. A.; Kelly, J. W.; Graef, I. A. Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte Proteotoxicity Sci. Transl. Med. 2011, 3, 97ra81
Connelly, S.; Choi, S.; Johnson, S. M.; Kelly, J. W.; Wilson, I. A. Structure-Based Design of Kinetic Stabilizers That Ameliorate the Transthyretin Amyloidoses Curr. Opin. Struct. Biol. 2010, 20, 54-62
Kumita, J. R.; Poon, S.; Caddy, G. L.; Hagan, C. L.; Dumoulin, M.; Yerbury, J. J.; Stewart, E. M.; Robinson, C. V.; Wilson, M. R.; Dobson, C. M. The Extracellular Chaperone Clusterin Potently Inhibits Human Lysozyme Amyloid Formation by Interacting with Prefibrillar Species J. Mol. Biol. 2007, 369, 157-167
Guilliams, T.; El-Turk, F.; Buell, A.; O'Day, E.; Aprile, F.; Esbjorner, E.; Vendruscolo, M.; Cremades, N.; Pardon, E.; Wyns, L. Nanobodies Raised against Monomeric α-Synuclein Distinguish between Fibrils at Different Maturation Stages J. Mol. Biol. 2013, 425, 2397-2411
De Genst, E. J.; Guilliams, T.; Wellens, J.; O'Day, E. M.; Waudby, C. A.; Meehan, S.; Dumoulin, M.; Hsu, S. T.; Cremades, N.; Verschueren, K. H. Structure and Properties of a Complex of α-Synuclein and a Single-Domain Camelid Antibody J. Mol. Biol. 2010, 402, 326-343
Wolynes, P. G.; Onuchic, J. N.; Thirumalai, D. Navigating the Folding Routes Science 1995, 267, 1619-1620
Wolynes, P. G. Folding Funnels and Energy Landscapes of Larger Proteins within the Capillarity Approximation Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 6170-6175
Wolynes, P. G.; Eaton, W. A.; Fersht, A. R. Chemical Physics of Protein Folding Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 17770-17771
Dobson, C. M.; Šali, A.; Karplus, M. Protein Folding: A Perspective from Theory and Experiment Angew. Chem., Int. Ed. Engl. 1998, 37, 868-893
Panchenko, A. R.; Luthey-Schulten, Z.; Wolynes, P. G. Foldons, Protein Structural Modules, and Exons Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 2008-2013
Brooks, C. L., 3rd; Gruebele, M.; Onuchic, J. N.; Wolynes, P. G. Chemical Physics of Protein Folding Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 11037-11038
Onuchic, J. N.; Wolynes, P. G. Theory of Protein Folding Curr. Opin. Struct. Biol. 2004, 14, 70-75
Ong, D. S.; Kelly, J. W. Chemical and/or Biological Therapeutic Strategies to Ameliorate Protein Misfolding Diseases Curr. Opin. Cell Biol. 2011, 23, 231-238
Zheng, W.; Schafer, N. P.; Wolynes, P. G. Frustration in the Energy Landscapes of Multidomain Protein Misfolding Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 1680-1685
Chiti, F.; Dobson, C. M. Protein Misfolding, Functional Amyloid, and Human Disease Annu. Rev. Biochem. 2006, 75, 333-366
Shoemaker, B. A.; Wolynes, P. G. Exploring Structures in Protein Folding Funnels with Free Energy Functionals: The Denatured Ensemble J. Mol. Biol. 1999, 287, 657-674
Dinner, A. R.; Šali, A.; Smith, L. J.; Dobson, C. M.; Karplus, M. Understanding Protein Folding via Free-Energy Surfaces from Theory and Experiment Trends Biochem. Sci. 2000, 25, 331-339